Compounds > conivaptan
Page last updated: 2024-09-04

conivaptan and Cirrhosis, Liver

conivaptan has been researched along with Cirrhosis, Liver in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (70.00)29.6817
2010's2 (20.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Avila-Blanco, ME; Calvillo-Robedo, A; González-Blas, D; Muñoz-Ortega, MH; Navarro-Gonzalez, YD; Quintanar-Stephano, A; Valdez-Urias, F; Ventura-Juarez, J1
Villabona, C1
Er, F; Fuhr, U; Gassanov, N; Nia, AM; Semmo, M; Semmo, N1
Ferguson, JW; Hayes, PC; Newby, DE; Therapondos, G1
Arroyo, V; Cano, C; Cejudo-Martín, P; Fernández-Varo, G; Jiménez, W; Rivera, F; Rodés, J; Ros, J1
Ginès, P; Guevara, M; Martín-Llahí, M1
Ali, F; Ghali, JK; Guglin, M; Vaitkevicius, P1
Głuszek, J; Olszewski, W1
Cárdenas, A; Ginès, P1

Reviews

8 review(s) available for conivaptan and Cirrhosis, Liver

ArticleYear
Tolvaptan (Samsca) for hyponatremia.
    The Medical letter on drugs and therapeutics, 2009, Nov-30, Volume: 51, Issue:1326

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiomyopathy, Dilated; Clinical Trials as Topic; Drug Approval; Drug Interactions; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Osmolar Concentration; Tolvaptan; United States; United States Food and Drug Administration

2009
[Vasopressin receptor antagonists: the vaptans].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2010, Volume: 57 Suppl 2

    Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Benzamides; Benzazepines; Calcium Signaling; Clinical Trials as Topic; Cyclic AMP; Double-Blind Method; Drug Therapy, Combination; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Liver Cirrhosis; Morpholines; Multicenter Studies as Topic; Neoplasms; Pituitary Gland, Anterior; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Second Messenger Systems; Spiro Compounds; Tolvaptan; Vasopressins

2010
Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH).
    European journal of clinical pharmacology, 2011, Volume: 67, Issue:4

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Diuretics; Heart Failure; Humans; Inappropriate ADH Syndrome; Liver Cirrhosis; Models, Biological; Morpholines; Pyrroles; Spiro Compounds; Tolvaptan; Water-Electrolyte Balance

2011
Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis.
    Clinical science (London, England : 1979), 2003, Volume: 105, Issue:1

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Diuretics; Heart Failure; Homeostasis; Humans; Inappropriate ADH Syndrome; Liver Cirrhosis; Models, Animal; Morpholines; Piperidines; Pyrroles; Quinolones; Rats; Spiro Compounds; Vasopressins

2003
Hyponatremia in cirrhosis: clinical features and management.
    Gastroenterologie clinique et biologique, 2006, Volume: 30, Issue:10

    Topics: Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Brain; Clinical Trials, Phase II as Topic; Controlled Clinical Trials as Topic; Creatinine; Forecasting; Hepatic Encephalopathy; Humans; Hyponatremia; Liver Cirrhosis; Liver Transplantation; Prognosis; Research; Risk Factors; Sodium; Time Factors; Treatment Outcome

2006
Therapeutic potential of vasopressin receptor antagonists.
    Drugs, 2007, Volume: 67, Issue:6

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan

2007
[Vasopressin antagonists in treatment of hyponatremia].
    Polskie Archiwum Medycyny Wewnetrznej, 2007, Volume: 117, Issue:8

    Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Sodium Chloride; Tolvaptan; Water-Electrolyte Balance

2007
The management of ascites and hyponatremia in cirrhosis.
    Seminars in liver disease, 2008, Volume: 28, Issue:1

    Topics: Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Diet, Sodium-Restricted; Diuretics; Humans; Hyponatremia; Liver Cirrhosis; Prognosis

2008

Other Studies

2 other study(ies) available for conivaptan and Cirrhosis, Liver

ArticleYear
Arginine vasopressin deficiency and conivaptan (a V1a-V2 receptor antagonist) treatment reverses liver damage and fibrosis in rats with chronic portocaval anastomosis.
    International journal of experimental pathology, 2023, Volume: 104, Issue:4

    Topics: Anastomosis, Surgical; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine; Arginine Vasopressin; Cricetinae; Diabetes Insipidus, Neurogenic; Liver Cirrhosis; Rats; Receptors, Vasopressin

2023
Effect of the V1a/V2-AVP receptor antagonist, Conivaptan, on renal water metabolism and systemic hemodynamics in rats with cirrhosis and ascites.
    Journal of hepatology, 2003, Volume: 38, Issue:6

    Topics: Administration, Oral; Animals; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Diuresis; Drug Administration Schedule; Hemodynamics; Kidney; Liver Cirrhosis; Male; Natriuresis; Osmolar Concentration; Rats; Rats, Wistar; Sodium; Urine; Water

2003